A study with 478 patients from Denmark diagnosed with moderate-to-severe psoriasis and treated with anti-TNF medication (n = 376) and with UTK (n = 230) assessed the effect of these polymorphisms on the treatment response (PASI 75 at 3 months) [71]. Here, TNF is linked to psoriasis.